Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Month of birth and risk of multiple sclerosis in Kuwait: A population-based registry study.
Multiple sclerosis. Recent modalities of treatment.
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions.
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis.
Botulinum Toxin-What Urologic Uses Does the Data Support?
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
Oxidised LDL lipids, statins and a blood-brain barrier.
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
Validation of an Arabic version of Fatigue Severity Scale.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
ANALYSIS OF MULTIPLE SCLEROSIS LESIONS VIA SPATIALLY VARYING COEFFICIENTS.
Nano- and micro-based systems for immunotolerance induction in Multiple Sclerosis.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Current standards of treatment in ms and the role of oral agents.
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »